Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome - Concepedia

Concepedia

Publication | Closed Access

Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome

319

Citations

34

References

2003

Year

Bas W.G. van Rhijn, André N. Vis, Theodorus van der Kwast, Wim J. Kirkels, François Radvanyi, E. C. M. Ooms, Dominique Chopin, Egbert R. Boevé, Adriaan C. Jöbsis, Ellen C. Zwarthoff

Journal of Clinical Oncology

Abstract

The FGFR3 mutation represents the favorable molecular pathway of UCC. Molecular grading provides a new, simple, and highly reproducible tool for clinical decision making in UCC patients.

References

	Year	Citations

Page 1